|
| Orientin |
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Wang L, et al. 2021. Virulence |
|
| Cyanidin chloride |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Su X, et al. 2022. Virulence |
|
| Rhodionin |
|
Staphylococcus |
Others; Adherence; Biofilm |
Preclinical (in vivo) |
Wang X, et al. 2022. World J Microbiol Biotechnol |
|
| Isovitexin |
|
Staphylococcus |
Others; Adherence |
Preclinical (in vivo) |
Tian L, et al. 2022. J Microbiol Biotechnol |
|
| Fisetin |
|
Acinetobacter
Klebsiella |
BfmRS
Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Raorane CJ, et al. 2019. Front Microbiol
Adeosun IJ, et al. 2022. Plants (Basel) |
|
| Luteolin |
|
Aeromonas |
Aerolysin |
Preclinical (in vitro) |
Dong J, et al. 2021. Virulence |
|
| (2R)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-4-methylpentanamide |
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
| (2R,3R)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
| (2S)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxyhexanamide |
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
| (2S,3S)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
| | | |
